Vanda Pharmaceuticals Inc (VNDA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access VNDA Annual Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Vanda Pharmaceuticals Inc finances operations and invests in assets.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent55.88
Restricted Cash and Cash Equivalents, Current0.10
Available-for-sale Securities, Debt Securities, Current MA0.13
Cash & Short-term Investments55.00
Accounts receivable59.69
Inventories1.68
Other Current Assets113.54
Prepaid Expense And Other Assets Current33.09
Total Current Assets264.48
Equipment/Property/Plant Net2.58
Intangible Assets113.12
Long-term investments0.37
Other Assets, Noncurrent31.92
Inventory And Other Non Current11.19
Total Assets412.47
Liabilities
Accounts Payable and Accrued Liabilities, Current LI69.99
Accrued Liabilities, Current AC8.12
Other Liabilities, Current85.92
Total Current Liabilities164.03
Total Long-term Debt0.00
Other liabilities, Noncurrent28.26
Product Revenue Allowances Current74.96
Total Liabilities192.28
Stockholders' Equity
Common Stock Value0.06
Additional Paid In Capital Common Stock725.93
Retained Earnings / Accumulated Deficit-505.85
Accumulated Other Comprehensive Income0.04
Other Equity0.04
Common Stockholder's Equity220.19
Total Stockholder's Equity220.19
Liabilities & Stockholder's Equity412.47
4 historic quarters locked

Sign in to unlock the full Vanda Pharmaceuticals Inc balance sheet history.

About Vanda Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-053855

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.